DSHS’s reinstatement of the 2021 controlled substances schedules did not change criminal penalties for selling consumable hemp products in Texas. Criminal exposure still turns on Texas penalty groups ...
A new continuing resolution pushes the federal total THC standard and 0.4 mg per-container cap for hemp products to December ...
The Drug Enforcement Administration’s chief administrative law judge has stayed the marijuana rescheduling proceeding while ...
The Office of Cannabis Management’s (OCM) September 10 Cannabis Advisory Board (CAB) meeting covered several items with near-term consequences for licensees. The most significant is that ...
On September 11, 2026, the Florida Department of Health announced its Final Order, officially closing the April 2023 Medical Marijuana Treatment Center (MMTC) application process and granting 22 new ...
The companies’ majority owner is a Michigan resident who was denied dispensary licenses in both Washington and Sacramento due to residency requirements. The criteria at issue included residency ...
Kratom, derived from the leaves of a Southeast Asian tree, is sold across the United States in supplements and beverages, and federal regulators have spent years evaluating whether specific ...
North Carolina has spent the better part of a decade as one of the most permissive hemp markets in the country. Walk into a shop in Raleigh, Asheville, or Wilmington today, and you’ll still find ...
Alcohol and Tobacco Tax and Trade Bureau (TTB) licensing governs which federal permits, registrations, formulas and label approvals an alcohol beverage business needs before it can produce, import or ...
A botanically derived, non-opioid pain treatment made from cannabis is moving through regulatory review in Europe and the United States, adding to growing evidence that supported the FDA’s 2024 ...
The Government still has the cleaner path to Schedule III. The opponents, however, may have built the better record for challenging the agency. Testimony in DEA’s marijuana-rescheduling proceeding ...
Texas synthetic cannabinoids are once again Schedule I controlled substances. In the July 10, 2026 edition of the Texas Register, the Texas Department of State Health Services (DSHS) published a ...